Symphony Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,399	Closed	-$717K	–	284
2018 Q2	$717K	Sell	4,399 -95	-2%	-$14.7K	0.14%	136
2018 Q1	$732K	Sell	4,494 -322	-7%	-$52.6K	0.09%	194
2017 Q4	$722K	Sell	4,816 -73	-1%	-$10.8K	0.07%	217
2017 Q3	$743K	Sell	4,889 -36	-0.7%	-$5.42K	0.08%	216
2017 Q2	$634K	Sell	4,925 -239	-5%	-$28.8K	0.07%	240
2017 Q1	$565K	Sell	5,164 -1,112	-18%	-$97.9K	0.05%	265
2016 Q4	$463K	Sell	6,276 -217	-3%	-$17.7K	0.05%	294
2016 Q3	$566K	Sell	6,493 -6,295	-49%	-$595K	0.06%	251
2016 Q2	$1.1M	Sell	12,788 -5,773	-31%	-$499K	0.12%	172
2016 Q1	$1.48M	Buy	18,561 +10,475	+130%	+$947K	0.16%	146
2015 Q4	$1.02M	Sell	8,086 -279	-3%	-$33.7K	0.11%	191
2015 Q3	$871K	Sell	8,365 -209	-2%	-$26.9K	0.11%	209
2015 Q2	$1.06M	Sell	8,574 -1,122	-12%	-$141K	0.13%	173
2015 Q1	$1.14M	Buy	9,696 +855	+10%	+$102K	0.13%	164
2014 Q4	$1.05M	Sell	8,841 -3,813	-30%	-$429K	0.13%	164
2014 Q3	$1.42M	Buy	12,654 +3,194	+34%	+$304K	0.15%	138
2014 Q2	$895K	Sell	9,460 -464	-5%	-$32.5K	0.09%	236
2014 Q1	$702K	Buy	+9,924	New	+$786K	0.07%	252